Next Article in Journal
Novel Gene Fusions in Glioblastoma Tumor Tissue and Matched Patient Plasma
Previous Article in Journal
Functional Link between miR-200a and ELK3 Regulates the Metastatic Nature of Breast Cancer
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Erratum

Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971

1
SSD Oncologia Molecolare e Angiogenesi, IRCCS Ospedale Policlinico San Martino, largo Rosanna Benzi 10, 16132 Genova, Italy
2
Anatomia Patologica, IRCCS Ospedale Policlinico San Martino, largo Rosanna Benzi 10, 16132 Genova, Italy
3
Anatomia patologica, Dipartimento di Scienze Chirurgiche e Diagnostiche Integrate (DISC), Università di Genova, 16132 Genova, Italy
4
Department of Pharmaceutical Sciences, Midwestern University, Campus Glendale, Glendale, AZ 85308, USA
5
Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, largo Rosanna Benzi 10, 16132 Genova, Italy
*
Author to whom correspondence should be addressed.
Cancers 2020, 12(5), 1226; https://doi.org/10.3390/cancers12051226
Submission received: 12 May 2020 / Accepted: 12 May 2020 / Published: 13 May 2020
The authors wish to make the following corrections to this paper [1]:
Please note that Midwestern University signed the technology transfer agreement very recently, this is the reason why we forgot to modify the conflict of interest statement in the last revision of the manuscript.
The “Conflicts of Interest” statement should be changed to:
Conflicts of Interest: M.J.O. is the CEO of Crenae Therapeutics which has licensed ASPH inhibitor technologies from Midwestern University. The other authors declare no conflict of interest.
The authors would like to apologize for any inconvenience caused to the readers by these changes.

Reference

  1. Benelli, R.; Costa, D.; Mastracci, L.; Grillo, F.; Olsen, M.J.; Barboro, P.; Poggi, A.; Ferrari, N. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971. [Google Scholar] [CrossRef] [PubMed] [Green Version]

Share and Cite

MDPI and ACS Style

Benelli, R.; Costa, D.; Mastracci, L.; Grillo, F.; Olsen, M.J.; Barboro, P.; Poggi, A.; Ferrari, N. Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971. Cancers 2020, 12, 1226. https://doi.org/10.3390/cancers12051226

AMA Style

Benelli R, Costa D, Mastracci L, Grillo F, Olsen MJ, Barboro P, Poggi A, Ferrari N. Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971. Cancers. 2020; 12(5):1226. https://doi.org/10.3390/cancers12051226

Chicago/Turabian Style

Benelli, Roberto, Delfina Costa, Luca Mastracci, Federica Grillo, Mark Jon Olsen, Paola Barboro, Alessandro Poggi, and Nicoletta Ferrari. 2020. "Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971" Cancers 12, no. 5: 1226. https://doi.org/10.3390/cancers12051226

APA Style

Benelli, R., Costa, D., Mastracci, L., Grillo, F., Olsen, M. J., Barboro, P., Poggi, A., & Ferrari, N. (2020). Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971. Cancers, 12(5), 1226. https://doi.org/10.3390/cancers12051226

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop